Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
JACC Adv ; 3(2): 100811, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38939382

RESUMO

Background: Systemic right ventricle (RV) dysfunction is associated with lower transplant-free survival (TFS) in hypoplastic left heart syndrome (HLHS), but the likelihood of functional improvement and utility of heart failure (HF) medications is not understood. Objectives: The authors aimed to describe TFS, HF medication use, and surgical interventions in HLHS patients with RV dysfunction with and without subsequent improvement in function. Methods: The SickKids HF Database is a retrospective cohort that includes all pediatric HLHS patients with RV dysfunction lasting >30 days. We compared TFS, HF medications, and surgical interventions in HLHS patients with and without functional normalization. Results: Of 99 patients with HLHS and RV dysfunction, 52% had normalized function for ≥30 days. TFS at 2 years after dysfunction onset was lower in those without normalization (14% vs 78%, P < 0.001). Patients without normalization were less likely to reach target dosing (TD) of HF medications (27% vs 47% on 1 medication at TD, P < 0.001) and undergo Fontan completion (7% vs 53%, P < 0.001). Clinical factors associated with improved TFS were normalization of function for ≥30 days, onset of dysfunction after bidirectional Glenn, and exposure to ACE inhibition. Conclusions: Our cohort of HLHS patients with systemic RV dysfunction demonstrated a novel finding of improved TFS in those with functional normalization for ≥30 days. Achieving TD of HF medications was associated with improved outcomes. This may reflect patient stability and tolerance for HF medication more than its therapeutic effect, but it can help inform decisions to proceed with surgical palliation or list for transplant.

2.
Front Pediatr ; 11: 1264751, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37928350

RESUMO

Introduction: Children with restrictive cardiomyopathy (RCM) traditionally have a poor prognosis, with most patients either dying or requiring heart transplantation within 2 years of diagnosis. The development of symptoms in RCM suggests advanced disease. However, as screening practices evolve and lead to diagnosis of early disease, identifying appropriate timing of transplant listing becomes increasingly important. In this context we compared outcomes of children with RCM presenting with clinical symptoms to those asymptomatic at initial presentation. Methods: This retrospective cohort study included 25 patients with RCM presenting to a quaternary care center between 2001 and 2018. Times to transplantation, death, and a composite outcome of adverse cardiac events (CPR, cardioversion, inotropic support, mechanical ventilation, mechanical support, or heart transplant) were compared between those symptomatic and asymptomatic at presentation. Results: At 2 years following diagnosis, patients asymptomatic at presentation had a significantly better transplant-free survival at 57% compared to 17% for symptomatic patients (p = 0.03). Those asymptomatic at diagnosis also had significantly improved cardiac event-free survival at 71% compared to symptomatic patients at 25% (p = 0.01). In multivariable analysis, cardiac symptoms at presentation remained an independent risk factor for heart-transplant or death [hazard ratio 5.17 (1.28-20.85), p = 0.02]. Conclusion: Patients with RCM who are symptomatic at time of diagnosis have significantly worse transplant-free survival and cardiac event-free survival. Given current practice variability in timing of transplant listing, the presence of any cardiac symptoms is an important negative prognostic marker and should prompt urgent transplant listing.

3.
Can J Cardiol ; 38(6): 754-762, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35122937

RESUMO

BACKGROUND: Left ventricular noncompaction (LVNC) is associated with genetic and phenotypic variability that influences outcomes. We aimed to identify risk factors for death or heart transplantation (HTx) in a paediatric LVNC cohort. METHODS: We reviewed patients < 18 years of age (2001-2018) with LVNC, either isolated (I-LVNC) or with dilated phenotype (D-LVNC), and at least mildly reduced left ventricular ejection fraction (EF). Patients with dilated cardiomyopathy (DCM) were included as control subjects. Descriptive statistics, multivariate analysis, and time-to-event analysis were used. RESULTS: We included 188 patients, 34 (18%) with I-LVNC, 37 (20%) with D-LVNC, and 117 (62%) with DCM. Overall median age at diagnosis was 1.08 years (interquartile range [IQR] 0.22-10.65) and median follow-up was 1.4 years (IQR 0.2-5.2) years. I-LVNC patients' median baseline LVEF was 47%, compared with 33% for D-LVNC, and 21% for DCM (P < 0.0001); 62% of I-LVNC patients developed moderate to severe LV dysfunction during follow-up. The incidence of death or transplantation was 43.6% in the overall cohort. Freedom from death or HTx at 10 years after diagnosis was 88.6% (95% CI 76%-100%) for I-LVNC, 47% (95% CI 29%-65%) for D-LVNC, and 42.3% (95% CI 33%-52%) for DCM. On multivariable analysis, baseline LVEF and LV end-diastolic diameter (LVEDD) z-score were associated with death or transplantation. Patients with a baseline LVEDD z-score > 4 and moderate to severe LV dysfunction had a transplantation-free survival of 38%. CONCLUSIONS: Baseline LV dilation and systolic dysfunction were independently associated with progression to death or HTx in LVNC patients.


Assuntos
Cardiomiopatias , Cardiomiopatia Dilatada , Transplante de Coração , Miocárdio Ventricular não Compactado Isolado , Disfunção Ventricular Esquerda , Cardiomiopatias/complicações , Cardiomiopatias/diagnóstico , Cardiomiopatia Dilatada/complicações , Criança , Dilatação , Humanos , Miocárdio Ventricular não Compactado Isolado/complicações , Miocárdio Ventricular não Compactado Isolado/diagnóstico , Volume Sistólico , Disfunção Ventricular Esquerda/complicações , Disfunção Ventricular Esquerda/diagnóstico , Função Ventricular Esquerda
4.
J Electromyogr Kinesiol ; 42: 143-150, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30121048

RESUMO

Women report more neck/shoulder musculoskeletal disorders in association to low-force, dexterous work. However, it is unclear if this may be due to gender differences in sensorimotor patterns while performing such tasks. Twenty-nine asymptomatic adult volunteers (15 men, 14 women) performed a neck/shoulder fatiguing task involving screwing and unscrewing bolts placed at shoulder height until scoring 8 on a Borg CR-10 scale. During the task, performance (bolts/min) was measured, and electromyography (EMG) was recorded at eight neck/shoulder muscle sites to compute Root Mean Square (RMS), Motor Variability and Normalized Mutual Information (NMI). Before and after the task, Purdue pegboard and shoulder joint position sense were measured. Even though muscle fatigue was evidenced by neck/shoulder EMG results, shoulder proprioception was not affected by the fatiguing task while screwing and Purdue pegboard performance actually improved (p < 0.001). Women displayed overall higher RMS and NMI values (e.g. 80% higher UT RMS, 42% higher AD RMS). Thus, although task performance and proprioception did not deteriorate and were not different between genders, gender differences in EMG measures may help understand the sex-specific muscle fatigue mechanisms associated to shoulder height dexterous work, and may help explain the higher rates of neck/shoulder injuries in women.


Assuntos
Fadiga Muscular , Mialgia/epidemiologia , Doenças Profissionais/epidemiologia , Propriocepção , Articulação do Ombro/fisiologia , Extremidade Superior/fisiologia , Feminino , Humanos , Masculino , Movimento , Contração Muscular , Músculo Esquelético/fisiologia , Mialgia/etiologia , Pescoço/fisiologia , Doenças Profissionais/etiologia , Fatores Sexuais , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA